Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Hyperhomocyst(e)inemia and hemostatic factors: the atherosclerosis risk in communities study.

Schreiner PJ, Wu KK, Malinow MR, Stinson VL, Szklo M, Nieto FJ, Heiss G.

Ann Epidemiol. 2002 May;12(4):228-36.

PMID:
11988410
2.

Relation of hormone-replacement therapy to measures of plasma fibrinolytic activity. Atherosclerosis Risk in Communities (ARIC) Study Investigators.

Shahar E, Folsom AR, Salomaa VV, Stinson VL, McGovern PG, Shimakawa T, Chambless LE, Wu KK.

Circulation. 1996 Jun 1;93(11):1970-5.

PMID:
8640970
3.

Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults.

Folsom AR, Qamhieh HT, Wing RR, Jeffery RW, Stinson VL, Kuller LH, Wu KK.

Arterioscler Thromb. 1993 Feb;13(2):162-9.

PMID:
8427853

Supplemental Content

Loading ...
Support Center